1. Anwar, M.M., Mahfouz, H.A., and Sayed, A.S., 1998, Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs, Comp. Biochem. Physiol. 119:493–591.
2. Banks, R.E., Patel, P.M., and Selby, P.J., 1995, Interleukin-12: a new player in cytokine therapy, Br. J. Cancer 71:655–659.
3. Bartsch, C. and Bartsch, H., 1993, Melatonin secretion in oncological patients: current results and methodological considerations, in: Advances in Pineal Research 7 (G.J.M. Maestroni and A.R.J. Reiter, eds.), pp. 283–301, John Libbey, London.
4. Becker, J., Veit, G., Handgretinger, R., Attanasio, G., Bruchett, G., Trenner, I., Niethammer, D., and Gupta, D., 1988, Circadian variations in the immunomodulatory role of the pineal gland, Neuroendocrinol. Lett. 10:65–80.
5. Ben-Nathan, D., Maestroni, G.J.M., and Conti, A., 1995, Protective effect of melatonin in mice infected with encephalitis viruses, Arch. Virol. 140:223–230.